Keating M - Search Results

1

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.

Kebriaei P, Singh H, Huls MH, Figliola MJ, Bassett R, Olivares S, Jena B, Dawson MJ, Kumaresan PR, Su S, Maiti S, Dai J, Moriarity B, Forget MA, Senyukov V, Orozco A, Liu T, McCarty J, Jackson RN, Moyes JS, Rondon G, Qazilbash M, Ciurea S, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Kantarjian H, Keating M, Wierda W, Do KA, Largaespada DA, Lee DA, Hackett PB, Champlin RE, Cooper LJ. Kebriaei P, et al. Among authors: keating m. J Clin Invest. 2016 Sep 1;126(9):3363-76. doi: 10.1172/JCI86721. Epub 2016 Aug 2. J Clin Invest. 2016. PMID: 27482888 Free PMC article. Clinical Trial.

2

Fludarabine phosphate therapy in other lymphoid malignancies.

Kantarjian HM, Redman JR, Keating MJ. Kantarjian HM, et al. Among authors: keating mj. Semin Oncol. 1990 Oct;17(5 Suppl 8):66-70. Semin Oncol. 1990. PMID: 1699285 Review.

3

Therapy-related leukemia and myelodysplastic syndrome.

Kantarjian HM, Keating MJ. Kantarjian HM, et al. Among authors: keating mj. Semin Oncol. 1987 Dec;14(4):435-43. Semin Oncol. 1987. PMID: 3321448 Review. No abstract available.

4

The eosinophilic variant of acute myelomonocytic leukemia developing as a secondary leukemia in a patient with mycosis fungoides.

Kantarjian HM, Keating MJ. Kantarjian HM, et al. Among authors: keating mj. Hematol Pathol. 1987;1(3):191-2. Hematol Pathol. 1987. PMID: 3509053 No abstract available.

5

Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications.

Kantarjian HM, Barlogie B, Keating MJ, Hall RR, Smith TL, McCredie KB, Freireich EJ. Kantarjian HM, et al. Among authors: keating mj. J Clin Invest. 1985 Jul;76(1):319-24. doi: 10.1172/JCI111964. J Clin Invest. 1985. PMID: 3860508 Free PMC article.

6

Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Case report and review.

Seymour JF, Khouri IF, Champlin RE, Keating MJ. Seymour JF, et al. Among authors: keating mj. Am J Clin Oncol. 1994 Aug;17(4):360-8. doi: 10.1097/00000421-199408000-00016. Am J Clin Oncol. 1994. PMID: 8048400 No abstract available.

7

Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.

Khouri IF, Keating MJ, Champlin R. Khouri IF, et al. Among authors: keating mj. Curr Opin Hematol. 1998 Nov;5(6):454-9. doi: 10.1097/00062752-199811000-00017. Curr Opin Hematol. 1998. PMID: 9814655 Review.

8

Allogeneic haematopoietic transplantation for Richter's syndrome.

Rodriguez J, Keating MJ, O'Brien S, Champlin RE, Khouri IF. Rodriguez J, et al. Among authors: keating mj. Br J Haematol. 2000 Sep;110(4):897-9. doi: 10.1046/j.1365-2141.2000.02295.x. Br J Haematol. 2000. PMID: 11054078 Free article.

9

Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation.

Khouri IF, Keating MJ, Saliba RM, Champlin RE. Khouri IF, et al. Among authors: keating mj. Cytotherapy. 2002;4(3):217-21. doi: 10.1080/146532402320219736. Cytotherapy. 2002. PMID: 12194718

10

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival.

Khouri IF, Lee MS, Saliba RM, Andersson B, Anderlini P, Couriel D, Hosing C, Giralt S, Korbling M, McMannis J, Keating MJ, Champlin RE. Khouri IF, et al. Among authors: keating mj. Exp Hematol. 2004 Jan;32(1):28-35. doi: 10.1016/j.exphem.2003.09.021. Exp Hematol. 2004. PMID: 14725898 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,541 results

Search Page